239 related articles for article (PubMed ID: 24246195)
1. Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy.
Saengkrit N; Saesoo S; Srinuanchai W; Phunpee S; Ruktanonchai UR
Colloids Surf B Biointerfaces; 2014 Feb; 114():349-56. PubMed ID: 24246195
[TBL] [Abstract][Full Text] [Related]
2. In vitro delivery of curcumin with cholesterol-based cationic liposomes.
Apiratikul N; Penglong T; Suksen K; Svasti S; Chairoungdua A; Yingyongnarongkula B
Bioorg Khim; 2013; 39(4):497-503. PubMed ID: 24707732
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
[TBL] [Abstract][Full Text] [Related]
4. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
5. Expression of luciferase plasmid (pCMVLuc) entrapped in DPPC/cholesterol/DDAB liposomes in HeLa cell lines.
Manosroi A; Thathang K; Manosroi J; Werner RG; Schubert R; Peschka-Süss R
J Liposome Res; 2009; 19(2):131-40. PubMed ID: 19515000
[TBL] [Abstract][Full Text] [Related]
6. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer.
Jose A; Labala S; Venuganti VV
J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148
[TBL] [Abstract][Full Text] [Related]
8. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
9. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
10. Effects of surface charge of low molecular weight heparin-modified cationic liposomes on drug efficacy and toxicity.
Li H; Chen Y; Deng Y; Wang Y; Ke X; Ci T
Drug Dev Ind Pharm; 2017 Jul; 43(7):1163-1172. PubMed ID: 28277844
[TBL] [Abstract][Full Text] [Related]
11. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
[TBL] [Abstract][Full Text] [Related]
12. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells.
Lin YL; Liu YK; Tsai NM; Hsieh JH; Chen CH; Lin CM; Liao KW
Nanomedicine; 2012 Apr; 8(3):318-27. PubMed ID: 21704596
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.
Dhule SS; Penfornis P; Frazier T; Walker R; Feldman J; Tan G; He J; Alb A; John V; Pochampally R
Nanomedicine; 2012 May; 8(4):440-51. PubMed ID: 21839055
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives.
Karewicz A; Bielska D; Loboda A; Gzyl-Malcher B; Bednar J; Jozkowicz A; Dulak J; Nowakowska M
Colloids Surf B Biointerfaces; 2013 Sep; 109():307-16. PubMed ID: 23668985
[TBL] [Abstract][Full Text] [Related]
15. One-Step Synthesis of Nanoscale Zeolitic Imidazolate Frameworks with High Curcumin Loading for Treatment of Cervical Cancer.
Zheng M; Liu S; Guan X; Xie Z
ACS Appl Mater Interfaces; 2015 Oct; 7(40):22181-7. PubMed ID: 26403308
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-mediated decrease in the expression of nucleolar organizer regions in cervical cancer (HeLa) cells.
Lewinska A; Adamczyk J; Pajak J; Stoklosa S; Kubis B; Pastuszek P; Slota E; Wnuk M
Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():43-52. PubMed ID: 25308441
[TBL] [Abstract][Full Text] [Related]
17. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
18. Development of highly stable and low toxic cationic liposomes for gene therapy.
Manosroi A; Thathang K; Werner RG; Schubert R; Peschka-Süss R; Manosroi J
Arzneimittelforschung; 2008; 58(10):485-92. PubMed ID: 19025056
[TBL] [Abstract][Full Text] [Related]
19. Combined ultrasound-curcumin treatment of human cervical cancer cells.
Carr KR; Ioffe YJ; Filippova M; Duerksen-Hughes P; Chan PJ
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():96-101. PubMed ID: 26262768
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
